Evolent Health Announces Second Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Evolent Health (EVH) PT Lowered to $33 at Cowen; Reiterates Outperform
August 8, 2017 7:42 AM EDTCowen lowered its price target on Evolent Health (NYSE: EVH) to $33.00 (from $35.00) while maintaining a Outperform rating following 2Q release. Reported revenues of $107.3M exceeded guidance, and consensus estimates, despite soft transformation sales. Adjusted EPS of ($0.13) was in-line with Street's expectations.
EVH... More
Evolent Health (EVH) Reports In-Line Q2 EPS
August 7, 2017 4:02 PM EDTEvolent Health (NYSE: EVH) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $107.3 million versus the consensus estimate of $104.45 million.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
... More